Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Connect Biopharmaceuticals is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. We believe that by creati...
Connect Biopharmaceuticals is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. We believe that by creating drug molecules that are disease pathway specific, we can deliver novel medicines with better efficacy and fewer side effects.

List your booth number for exhibitions, ask us